OLUSHOLA OLORUNNIPA

Concepts (59)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prone Position
1
2021
33
0.720
Why?
Facial Injuries
1
2021
21
0.720
Why?
Patient Positioning
1
2021
57
0.700
Why?
Pressure Ulcer
1
2021
79
0.690
Why?
Mammaplasty
2
2020
54
0.260
Why?
Dentition
1
2021
5
0.190
Why?
Mastectomy, Subcutaneous
1
2020
2
0.170
Why?
Nipples
1
2020
7
0.170
Why?
Perforator Flap
1
2020
9
0.170
Why?
Respiration, Artificial
1
2021
501
0.140
Why?
Endoscopy
1
2018
287
0.130
Why?
Craniosynostoses
1
2018
134
0.120
Why?
Granular Cell Tumor
1
2014
3
0.110
Why?
Breast Neoplasms
2
2020
2768
0.110
Why?
Thoracic Wall
1
2014
40
0.110
Why?
Mastectomy
1
2013
81
0.110
Why?
Angiography
1
2013
215
0.100
Why?
Surgical Flaps
1
2013
196
0.090
Why?
Skin
1
2013
553
0.090
Why?
Ischemia
1
2013
384
0.080
Why?
HIV-2
1
2006
8
0.070
Why?
Gene Products, tat
1
2006
28
0.070
Why?
HIV Antibodies
1
2006
71
0.060
Why?
Aged
2
2021
21704
0.060
Why?
Esthetics
1
2020
38
0.040
Why?
Humans
6
2021
133827
0.040
Why?
Blood Loss, Surgical
1
2018
158
0.030
Why?
Patient Satisfaction
1
2020
485
0.030
Why?
Male
1
2021
65923
0.030
Why?
Mastectomy, Segmental
1
2014
40
0.030
Why?
Sentinel Lymph Node Biopsy
1
2014
71
0.030
Why?
Middle Aged
4
2020
29338
0.030
Why?
HIV Infections
1
2006
2072
0.030
Why?
Coloring Agents
1
2013
78
0.030
Why?
Carcinoma, Ductal, Breast
1
2014
93
0.030
Why?
Indocyanine Green
1
2013
62
0.030
Why?
Incidental Findings
1
2014
129
0.030
Why?
Necrosis
1
2013
221
0.030
Why?
Lasers
1
2013
115
0.030
Why?
Intraoperative Care
1
2013
120
0.030
Why?
Lymph Node Excision
1
2014
175
0.030
Why?
Length of Stay
1
2018
1388
0.020
Why?
Neoplasm Invasiveness
1
2014
670
0.020
Why?
Retrospective Studies
2
2020
17441
0.020
Why?
Adult
3
2020
31909
0.020
Why?
Female
4
2020
71686
0.020
Why?
tat Gene Products, Human Immunodeficiency Virus
1
2006
32
0.020
Why?
Postoperative Complications
1
2018
3167
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
866
0.010
Why?
United States
1
2020
11720
0.010
Why?
Immunoglobulin G
1
2006
824
0.010
Why?
Prospective Studies
1
2013
6599
0.010
Why?
Infant
1
2018
13177
0.010
Why?
Survival Analysis
1
2006
1597
0.010
Why?
Treatment Outcome
1
2018
13021
0.010
Why?
Longitudinal Studies
1
2006
1499
0.010
Why?
Disease Progression
1
2006
2249
0.010
Why?
Time Factors
1
2006
6587
0.010
Why?
Risk Factors
1
2006
11133
0.010
Why?
OLORUNNIPA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_